US Bancorp DE Buys 310 Shares of Waters Corporation $WAT

US Bancorp DE raised its stake in Waters Corporation (NYSE:WAT) by 13.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,681 shares of the medical instruments supplier’s stock after buying an additional 310 shares during the period. US Bancorp DE’s holdings in Waters were worth $936,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. QRG Capital Management Inc. raised its stake in Waters by 85.7% during the 1st quarter. QRG Capital Management Inc. now owns 1,642 shares of the medical instruments supplier’s stock worth $605,000 after buying an additional 758 shares during the period. Swedbank AB lifted its holdings in shares of Waters by 25.8% in the second quarter. Swedbank AB now owns 40,526 shares of the medical instruments supplier’s stock valued at $14,145,000 after purchasing an additional 8,305 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Waters by 5.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 530,697 shares of the medical instruments supplier’s stock valued at $195,599,000 after purchasing an additional 28,018 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its holdings in Waters by 4.6% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 2,986 shares of the medical instruments supplier’s stock worth $1,101,000 after acquiring an additional 130 shares during the period. Finally, Jacobs Levy Equity Management Inc. purchased a new stake in Waters in the first quarter worth $1,244,000. Institutional investors own 94.01% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on WAT. Wall Street Zen cut Waters from a “buy” rating to a “hold” rating in a research report on Saturday, July 26th. Redburn Partners set a $390.00 price objective on Waters in a report on Wednesday, October 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a report on Wednesday, October 8th. Jefferies Financial Group set a $385.00 target price on Waters and gave the company a “buy” rating in a report on Monday, August 4th. Finally, Robert W. Baird dropped their target price on Waters from $374.00 to $352.00 and set an “outperform” rating for the company in a report on Wednesday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Waters currently has an average rating of “Moderate Buy” and an average target price of $376.80.

Waters Stock Performance

Shares of WAT opened at $335.58 on Friday. The business’s fifty day simple moving average is $305.36 and its two-hundred day simple moving average is $323.15. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The company has a market cap of $19.97 billion, a price-to-earnings ratio of 30.26, a P/E/G ratio of 3.12 and a beta of 1.04.

Waters (NYSE:WAT) last issued its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%.The business had revenue of $608.55 million for the quarter. Research analysts anticipate that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.